Quick Dispatch:
Your glp-1 and parkinson's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases | CNS Drugs orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and parkinson's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases | CNS Drugs ships.
Need Help?
Questions about glp-1 and parkinson's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases | CNS Drugs, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and parkinson's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases | CNS Drugs in your area.
The Emerging Role of GLP-1 RAs in Parkinson's Disease
25.93
Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep
29.37
Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease
29.61
GLP-1 Receptor Agonists for Parkinson's Disease: Promise or Mirage?
25.85
![PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models](https://figures.semanticscholar.org/d83a64f6b7193358c31030487761fc19c80dd33c/3-Figure1-1.png)
PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
22.89
Frontiers
23.10
Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease
27.44
